Answer
Nirogacestat has an estimated apparent terminal elimination half-life of about 23 hours in patients with desmoid tumours, based on population pharmacokinetic analysis.
Sources for this answer
- Ogsiveo 150 mg film coated tabletsMerck · emc · SmPC §5.2 Pharmacokinetic properties · Version 2Document updated
Sources checked